Skip to main content
. 2022 Sep 12;2022:8559176. doi: 10.1155/2022/8559176

Table 5.

Other scoring indicators used to evaluate menopausal syndrome.

Index Numer of studies Study ID (Author, year) Cases of experimental group Cases of control group MD [95%CI] Z-value P value
MENQOL (BC) 1 Han and Wan 2020 66 67 −0.79 [−0.89, −0.69] 14.79 <0.00001
MENQOL (psychological) 1 Han and Wan 2020 66 67 −0.79 [−0.88, −0.70] 16.71 <0.00001
MENQOL (body) 1 Han and Wan 2020 66 67 −0.97 [−1.05, −0.89] 23.69 <0.00001
MENQOL (sex) 1 Han and Wan 2020 66 67 −0.81 [−0.86, −0.76] 31.7 <0.00001
SAS 1 Han and Wan 2020 66 67 −4.18 [−5.75, -2.61] 5.21 <0.00001
SDS 1 Han and Wan 2020 66 67 −3.33 [−4.94, −1.72] 4.04 <0.00001
PSQI 1 Han and Wan 2020 66 67 −0.92 [−1.12, −0.72] 9.02 <0.00001
YDFPS 1 Han and Wan 2020 66 67 −3.13 [−3.61, −2.65] 12.88 <0.00001
KMI 2 Han and Wan 2020
Xie 2020
96 97 −3.83 [−4.56, −3.11] 10.35 <0.00001
QL 1 Shen 2019 50 50 14.00 [8.31, 19.69] 4.82 <0.00001
HAMD 1 Song 2018 30 30 −1.34 [−2.49, -0.19] 2.28 0.02
HAMA 1 Song 2018 30 30 −1.87 [−3.32, −0.42] 2.54 0.01